Skip to content

The Step Back Up trial: the feasibility of a pedometer driven walking programme for chronic low back pain

A pedometer driven walking programme for chronic low back pain: a single centre, randomised, feasibility trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN67030896
Enrollment
50
Registered
2009-06-17
Start date
2009-09-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic low back pain Musculoskeletal Diseases Dorsalgia

Interventions

Walking Group: Graded, individually tailored, pedometer (Yamax Digiwalker SW-200, Yamax, Japan) driven walking programme given by a physiotherapist. This will be based on baseline assessment of PA us

Sponsors

University of Ulster (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults (aged 18 - 65 years, either sex) with a diagnosis of chronic low back pain (defined as pain and discomfort localised below the costal margin and above the inferior gluteal folds, with or without referred leg pain, persisting for more than 12 weeks)

Exclusion criteria

Exclusion criteria: 1. Any potential participant with a high level of physical activity (assessed by the International Physical Activity Questionnaire [IPAQ]) at initial screening 2. Any potential participant taking more than an average of 8,500 steps per day (recorded by an accelerometer) over 7 days prior to randomisation

Design outcomes

Primary

MeasureTime frame
Oswestry Disability Questionnaire (ODQ). All outcome measures will be assessed at baseline, at eight weeks (on completion of trial) and at six months. All follow up outcomes shall be assessed by a researcher blinded to group allocation.

Secondary

MeasureTime frame
1. Objective measurement of PA level (assessed by accelerometry) 2. International Physical Activity Questionnaire [IPAQ] - short form 3. Fear-Avoidance Beliefs Questionnaire (FABQ) 4. General Perceived Self-Efficacy Scale (GPSES) 5. Health outcomes (changes in body mass index [BMI kg/m^2], waist:hip ratio and resting blood pressures) 6. Stage of change questionnaire 7. Patient Preference 8. Participant Satisfaction Questionnaire All outcome measures will be assessed at baseline, at eight weeks (on completion of trial) and at six months. All follow up outcomes shall be assessed by a researcher blinded to group allocation.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 31, 2026